Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
_1_256_384.png)
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
With the launch of QurOne, the brand aims to redefine healthcare in the country with seamless, hassle-free patient care and hyper-coordinated workflows
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
Subscribe To Our Newsletter & Stay Updated
